tradingkey.logo
tradingkey.logo
Search

Ascentage Pharma Group International

AAPG
Add to Watchlist
15.580USD
0.0000.00%
Market hours 09/16, 15:19ET
1.45BMarket Cap
0.00P/E TTM

AAPG Financials

See Ascentage Pharma Group International's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Key Financial Ratios

Market Cap
1.45B
Dividend TTM
0.00
P/E TTM
0.00
EPS TTM
0.00
Revenue
83.19M
Net Profit
0.00
ROE
0.00%
ROA
0.00%

Ascentage Pharma Group International Earnings Date

Latest Release
Aug 20, 2026
EPS / Forecast
--/--
Revenue / Forecast
--/--

Financial Statement Highlights

Quarterly
Quarterly+Annual
Quarterly
Annual
FY2025H2
Financial Indicators
Revenue
126.46%48.68M
Net Profit
-19.72%-93.23M
Revenue
126.46%48.68M
Operating profit
-25.44%-97.31M
Net Profit
-19.72%-93.23M
Current assets
108.46%421.01M
Total current liabilities
47.04%235.00M
Total assets
58.04%566.78M
Total liabilities
17.10%375.99M
Total equity
407.96%190.79M
Net operating income
-471.33%-109.70M
Net investment
-33.68%-42.26M
Net financing
3178.50%230.87M

FAQs

What is the total revenue of Ascentage Pharma Group International?

According to Ascentage Pharma Group International's FY2025 earnings report, its total revenue reached 83.19M, with a year-on-year change of 134.35M.

What are the current assets of Ascentage Pharma Group International?

According to Ascentage Pharma Group International's FY2025 earnings report, its current assets were 426.62M, with a year-on-year change of 111.24.

What are the total assets of Ascentage Pharma Group International?

According to Ascentage Pharma Group International's FY2025 earnings report, its total assets of Ascentage Pharma Group International were 574.34M, with a year-on-year change of 60.14.

What are the total liabilities of Ascentage Pharma Group International?

According to Ascentage Pharma Group International's FY2025 earnings report, its total liabilities of Ascentage Pharma Group International were 381.01M, with a year-on-year change of 18.66.

What is the total equity of Ascentage Pharma Group International?

According to Ascentage Pharma Group International's FY2025 earnings report, its total equity of Ascentage Pharma Group International was 193.33M, with a year-on-year change of 414.73.

What is the net operating income of Ascentage Pharma Group International?

According to Ascentage Pharma Group International's FY2025 earnings report, its net operating income of Ascentage Pharma Group International was -178.02M, with a year-on-year change of -245.14.

What is the net investment of Ascentage Pharma Group International?

According to Ascentage Pharma Group International's FY2025 earnings report, its net investment of Ascentage Pharma Group International was -144.91M, with a year-on-year change of -192.17.

What is the net financing of Ascentage Pharma Group International?

According to Ascentage Pharma Group International's FY2025 earnings report, its net financing of Ascentage Pharma Group International was 375.51M, with a year-on-year change of 630.29.

What is the net income of Ascentage Pharma Group International?

According to Ascentage Pharma Group International's FY2025 earnings report, its net income was -180.08M, with a year-on-year change of -224.22.

What is the operating profit of Ascentage Pharma Group International?

According to Ascentage Pharma Group International's FY2025 earnings report, its operating profit was -178.02M, with a year-on-year change of -245.14.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.